Rank | Gene Set | Z-score |
---|---|---|
1 | ribosomal small subunit assembly (GO:0000028) | 6.79637972 |
2 | DNA deamination (GO:0045006) | 5.91378110 |
3 | viral transcription (GO:0019083) | 5.70405102 |
4 | translational termination (GO:0006415) | 5.41461634 |
5 | translational elongation (GO:0006414) | 4.93127462 |
6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.92280988 |
7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.92280988 |
8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.68310414 |
9 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.65794948 |
10 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.63743678 |
11 | protein targeting to ER (GO:0045047) | 4.55434022 |
12 | cotranslational protein targeting to membrane (GO:0006613) | 4.50377784 |
13 | viral life cycle (GO:0019058) | 4.39496992 |
14 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.33898734 |
15 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.32041149 |
16 | protein localization to endoplasmic reticulum (GO:0070972) | 4.30929689 |
17 | ribosomal small subunit biogenesis (GO:0042274) | 4.21368158 |
18 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.21046190 |
19 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.17684934 |
20 | cellular protein complex disassembly (GO:0043624) | 4.14684032 |
21 | translational initiation (GO:0006413) | 4.13239369 |
22 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.03539236 |
23 | Golgi transport vesicle coating (GO:0048200) | 3.99622044 |
24 | COPI coating of Golgi vesicle (GO:0048205) | 3.99622044 |
25 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.98615473 |
26 | protein complex disassembly (GO:0043241) | 3.88815128 |
27 | maturation of SSU-rRNA (GO:0030490) | 3.87109250 |
28 | negative regulation of cell size (GO:0045792) | 3.83864051 |
29 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.80616659 |
30 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.78815740 |
31 | negative regulation of necroptotic process (GO:0060546) | 3.71635358 |
32 | cellular response to zinc ion (GO:0071294) | 3.65564563 |
33 | NADH metabolic process (GO:0006734) | 3.65056843 |
34 | macromolecular complex disassembly (GO:0032984) | 3.62348913 |
35 | regulation of gamma-delta T cell activation (GO:0046643) | 3.55683381 |
36 | pinocytosis (GO:0006907) | 3.51480760 |
37 | regulation of necrotic cell death (GO:0010939) | 3.45608550 |
38 | formation of translation preinitiation complex (GO:0001731) | 3.32855519 |
39 | negative regulation of necrotic cell death (GO:0060547) | 3.30444582 |
40 | glucose catabolic process (GO:0006007) | 3.30029697 |
41 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.29899241 |
42 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.27200345 |
43 | protein localization to endosome (GO:0036010) | 3.25963969 |
44 | regulation of necroptotic process (GO:0060544) | 3.25357114 |
45 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.24886884 |
46 | modulation by virus of host process (GO:0019054) | 3.24664875 |
47 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.21813977 |
48 | positive regulation of B cell differentiation (GO:0045579) | 3.19611381 |
49 | modulation by symbiont of host cellular process (GO:0044068) | 3.19549124 |
50 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.17953454 |
51 | proline biosynthetic process (GO:0006561) | 3.16183197 |
52 | NADPH regeneration (GO:0006740) | 3.16065576 |
53 | protein retention in ER lumen (GO:0006621) | 3.15040724 |
54 | protein targeting to membrane (GO:0006612) | 3.13847023 |
55 | mRNA catabolic process (GO:0006402) | 3.13810910 |
56 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.12921051 |
57 | DNA unwinding involved in DNA replication (GO:0006268) | 3.09805002 |
58 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.08991102 |
59 | protein maturation by protein folding (GO:0022417) | 3.08200649 |
60 | DNA strand elongation (GO:0022616) | 3.07654125 |
61 | GDP-mannose metabolic process (GO:0019673) | 3.04274935 |
62 | ribosomal large subunit biogenesis (GO:0042273) | 3.03900571 |
63 | barbed-end actin filament capping (GO:0051016) | 3.00469387 |
64 | RNA catabolic process (GO:0006401) | 2.96700594 |
65 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.95472152 |
66 | translation (GO:0006412) | 2.94032576 |
67 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.93309721 |
68 | cellular hyperosmotic response (GO:0071474) | 2.91559027 |
69 | B cell receptor signaling pathway (GO:0050853) | 2.89903193 |
70 | response to interferon-beta (GO:0035456) | 2.89095352 |
71 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.87421488 |
72 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.87047281 |
73 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.85011259 |
74 | embryonic process involved in female pregnancy (GO:0060136) | 2.84599392 |
75 | regulation of B cell differentiation (GO:0045577) | 2.84404695 |
76 | endosome to pigment granule transport (GO:0043485) | 2.84149146 |
77 | endosome to melanosome transport (GO:0035646) | 2.84149146 |
78 | response to peptidoglycan (GO:0032494) | 2.82652611 |
79 | viral mRNA export from host cell nucleus (GO:0046784) | 2.81598193 |
80 | purine-containing compound salvage (GO:0043101) | 2.81248386 |
81 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.80595701 |
82 | ncRNA 3-end processing (GO:0043628) | 2.78941673 |
83 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.78915733 |
84 | T cell homeostasis (GO:0043029) | 2.78553683 |
85 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.78296365 |
86 | negative regulation of RNA splicing (GO:0033119) | 2.78058803 |
87 | UV protection (GO:0009650) | 2.76507228 |
88 | sequestering of actin monomers (GO:0042989) | 2.75675444 |
89 | positive regulation of lamellipodium assembly (GO:0010592) | 2.75076872 |
90 | cellular response to virus (GO:0098586) | 2.73289089 |
91 | apoptotic process involved in morphogenesis (GO:0060561) | 2.69786717 |
92 | positive regulation of granulocyte differentiation (GO:0030854) | 2.69108110 |
93 | platelet dense granule organization (GO:0060155) | 2.66272778 |
94 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.64976383 |
95 | negative regulation of skeletal muscle tissue development (GO:0048642) | 2.63033233 |
96 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.62824532 |
97 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.59977900 |
98 | iron-sulfur cluster assembly (GO:0016226) | 2.58415575 |
99 | metallo-sulfur cluster assembly (GO:0031163) | 2.58415575 |
100 | regulation of regulatory T cell differentiation (GO:0045589) | 2.58132519 |
101 | pentose-phosphate shunt (GO:0006098) | 2.55803424 |
102 | negative regulation of innate immune response (GO:0045824) | 2.54832840 |
103 | tricarboxylic acid metabolic process (GO:0072350) | 2.53775730 |
104 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.53569898 |
105 | oxidative phosphorylation (GO:0006119) | 2.52653640 |
106 | pentose metabolic process (GO:0019321) | 2.51279685 |
107 | telomere maintenance via recombination (GO:0000722) | 2.50751125 |
108 | nuclear envelope reassembly (GO:0031468) | 2.50575876 |
109 | mitotic nuclear envelope reassembly (GO:0007084) | 2.50575876 |
110 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.50247203 |
111 | stress fiber assembly (GO:0043149) | 2.49900737 |
112 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.49638771 |
113 | regulation of erythrocyte differentiation (GO:0045646) | 2.48497287 |
114 | creatine metabolic process (GO:0006600) | 2.48355751 |
115 | cell-substrate adherens junction assembly (GO:0007045) | 2.48297530 |
116 | focal adhesion assembly (GO:0048041) | 2.48297530 |
117 | regulation of response to osmotic stress (GO:0047484) | 2.47140641 |
118 | heme biosynthetic process (GO:0006783) | 2.46530715 |
119 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.46158826 |
120 | negative regulation of cell killing (GO:0031342) | 2.46103158 |
121 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.46103158 |
122 | regulation of defense response to virus by virus (GO:0050690) | 2.42982673 |
123 | protein-DNA complex disassembly (GO:0032986) | 2.41409524 |
124 | nucleosome disassembly (GO:0006337) | 2.41409524 |
125 | modulation by virus of host morphology or physiology (GO:0019048) | 2.41388061 |
126 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.41175339 |
127 | positive thymic T cell selection (GO:0045059) | 2.41088275 |
128 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.41054853 |
129 | positive regulation of lamellipodium organization (GO:1902745) | 2.40908442 |
130 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.40664070 |
131 | regulation of superoxide anion generation (GO:0032928) | 2.40367462 |
132 | regulation of leukocyte degranulation (GO:0043300) | 2.39732719 |
133 | virion assembly (GO:0019068) | 2.39373406 |
134 | neutrophil activation involved in immune response (GO:0002283) | 2.38869484 |
135 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.38515295 |
136 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.38339414 |
137 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.37908481 |
138 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.37908481 |
139 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.37908481 |
140 | modulation by symbiont of host immune response (GO:0052553) | 2.37908481 |
141 | positive regulation by symbiont of host defense response (GO:0052509) | 2.37908481 |
142 | modulation by symbiont of host defense response (GO:0052031) | 2.37908481 |
143 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.36865043 |
144 | secretory granule organization (GO:0033363) | 2.36583170 |
145 | defense response to protozoan (GO:0042832) | 2.36358425 |
146 | immunoglobulin mediated immune response (GO:0016064) | 2.36320566 |
147 | positive regulation of myotube differentiation (GO:0010831) | 2.36227051 |
148 | response to laminar fluid shear stress (GO:0034616) | 2.35776468 |
149 | mitochondrial calcium ion transport (GO:0006851) | 2.34994979 |
150 | adherens junction assembly (GO:0034333) | 2.33535890 |
151 | regulation of protein heterodimerization activity (GO:0043497) | 2.33407831 |
152 | response to muramyl dipeptide (GO:0032495) | 2.32436031 |
153 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.32210313 |
154 | granulocyte differentiation (GO:0030851) | 2.31634016 |
155 | NIK/NF-kappaB signaling (GO:0038061) | 2.31335270 |
156 | mannose metabolic process (GO:0006013) | 2.30977106 |
157 | mitochondrial fusion (GO:0008053) | 2.30431674 |
158 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.30081233 |
159 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.29954294 |
160 | negative regulation of myotube differentiation (GO:0010832) | 2.29843169 |
161 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.29599959 |
162 | regulation of mast cell degranulation (GO:0043304) | 2.28970480 |
163 | megakaryocyte development (GO:0035855) | 2.28558052 |
164 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.28132280 |
165 | protein targeting to plasma membrane (GO:0072661) | 2.27625813 |
166 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.27476498 |
167 | response to protozoan (GO:0001562) | 2.27395128 |
168 | thymic T cell selection (GO:0045061) | 2.27045193 |
169 | spliceosomal snRNP assembly (GO:0000387) | 2.26576499 |
170 | cellular response to interleukin-4 (GO:0071353) | 2.26558085 |
171 | regulation of response to interferon-gamma (GO:0060330) | 2.26521870 |
172 | rRNA processing (GO:0006364) | 2.26348029 |
173 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.25470095 |
174 | morphogenesis of an endothelium (GO:0003159) | 2.24662854 |
175 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.24437564 |
176 | muscle filament sliding (GO:0030049) | 2.24403128 |
177 | actin-myosin filament sliding (GO:0033275) | 2.24403128 |
178 | negative regulation of stress fiber assembly (GO:0051497) | 2.22330427 |
179 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.22015212 |
180 | response to thyroid hormone (GO:0097066) | 2.21519419 |
181 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.21170635 |
182 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.20764966 |
183 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 2.19215343 |
184 | amyloid precursor protein catabolic process (GO:0042987) | 2.19019567 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.69882035 |
2 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.23043002 |
3 | MYC_22102868_ChIP-Seq_BL_Human | 2.89096319 |
4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.66414675 |
5 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.63129905 |
6 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.39783345 |
7 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.39318068 |
8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.39235997 |
9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.23516343 |
10 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.19723424 |
11 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18951602 |
12 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.17595200 |
13 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.15793660 |
14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.12775206 |
15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.12227770 |
16 | * HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.11254014 |
17 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.10693375 |
18 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.09205887 |
19 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.09108591 |
20 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.07136526 |
21 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.07036730 |
22 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.04105825 |
23 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.98407753 |
24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.98029749 |
25 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.94335782 |
26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.94296690 |
27 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.93211924 |
28 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.92797291 |
29 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.85621445 |
30 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.83970145 |
31 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.81320238 |
32 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.79592785 |
33 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.79523588 |
34 | MAF_26560356_Chip-Seq_TH1_Human | 1.78635826 |
35 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.75626916 |
36 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75045713 |
37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.73871905 |
38 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.72392125 |
39 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.68444003 |
40 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.64844108 |
41 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.62269033 |
42 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.61508212 |
43 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.58160858 |
44 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.56102913 |
45 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.55700102 |
46 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.54719656 |
47 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.54137474 |
48 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.54010885 |
49 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.53852553 |
50 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.52825701 |
51 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.50872622 |
52 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.50567253 |
53 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.50489556 |
54 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.50399879 |
55 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.48818160 |
56 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.48252928 |
57 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47602198 |
58 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.47445760 |
59 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.45997565 |
60 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.45602847 |
61 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.44466512 |
62 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.44361080 |
63 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.43705766 |
64 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.43546343 |
65 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.43203544 |
66 | MAF_26560356_Chip-Seq_TH2_Human | 1.41509865 |
67 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.40687665 |
68 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.38758918 |
69 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.38726223 |
70 | MYB_26560356_Chip-Seq_TH2_Human | 1.38418284 |
71 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.38302347 |
72 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.38077451 |
73 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.36493780 |
74 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.33656211 |
75 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.32926098 |
76 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.32799873 |
77 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.32782711 |
78 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.32000083 |
79 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.30067889 |
80 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.29723583 |
81 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.28186394 |
82 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27848231 |
83 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.27558171 |
84 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.27488032 |
85 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26139204 |
86 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.25895823 |
87 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.24736942 |
88 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.24246714 |
89 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.24108862 |
90 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.23516534 |
91 | MYB_26560356_Chip-Seq_TH1_Human | 1.22863472 |
92 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.22182182 |
93 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.21833133 |
94 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.21744596 |
95 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.21171968 |
96 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.20836557 |
97 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.20609625 |
98 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.20195823 |
99 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.20053621 |
100 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19322339 |
101 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.18910868 |
102 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.17970584 |
103 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.17489238 |
104 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.17189362 |
105 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16706398 |
106 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.16229768 |
107 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.15624894 |
108 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15367836 |
109 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.13654087 |
110 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.13448455 |
111 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.12621677 |
112 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.12405375 |
113 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.12008518 |
114 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.11992653 |
115 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11516562 |
116 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.11192732 |
117 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.10810404 |
118 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10743819 |
119 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.10646229 |
120 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.10458529 |
121 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.09933270 |
122 | KDM2B_26808549_Chip-Seq_K562_Human | 1.09810118 |
123 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.09655848 |
124 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.09299963 |
125 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09290404 |
126 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.08884482 |
127 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.08662903 |
128 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.08580340 |
129 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.08423773 |
130 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.08360025 |
131 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.08281698 |
132 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08201876 |
133 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.07854128 |
134 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.07791927 |
135 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07685856 |
136 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.07443449 |
137 | P68_20966046_ChIP-Seq_HELA_Human | 1.07393060 |
138 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.07265205 |
139 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.07051876 |
140 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.06649626 |
141 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.06321274 |
142 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.06154719 |
143 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.06142386 |
144 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.02495651 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005451_abnormal_body_composition | 4.37638340 |
2 | MP0003763_abnormal_thymus_physiology | 3.18110775 |
3 | MP0000685_abnormal_immune_system | 3.10785309 |
4 | MP0001835_abnormal_antigen_presentation | 2.86073999 |
5 | MP0002396_abnormal_hematopoietic_system | 2.83379791 |
6 | MP0008260_abnormal_autophagy | 2.80410460 |
7 | MP0005671_abnormal_response_to | 2.61740616 |
8 | MP0004808_abnormal_hematopoietic_stem | 2.49872861 |
9 | MP0003705_abnormal_hypodermis_morpholog | 2.45964810 |
10 | MP0002398_abnormal_bone_marrow | 2.44337803 |
11 | MP0001545_abnormal_hematopoietic_system | 2.36153670 |
12 | MP0005397_hematopoietic_system_phenotyp | 2.36153670 |
13 | MP0003693_abnormal_embryo_hatching | 2.25328319 |
14 | MP0000490_abnormal_crypts_of | 2.22346671 |
15 | MP0001800_abnormal_humoral_immune | 2.19470617 |
16 | MP0002420_abnormal_adaptive_immunity | 2.15418584 |
17 | MP0009785_altered_susceptibility_to | 2.12907395 |
18 | MP0001819_abnormal_immune_cell | 2.12348170 |
19 | MP0004185_abnormal_adipocyte_glucose | 2.11815708 |
20 | MP0009333_abnormal_splenocyte_physiolog | 2.09094138 |
21 | MP0002722_abnormal_immune_system | 2.08282597 |
22 | MP0000689_abnormal_spleen_morphology | 2.07962565 |
23 | MP0000465_gastrointestinal_hemorrhage | 2.05817022 |
24 | MP0002452_abnormal_antigen_presenting | 2.02764601 |
25 | MP0009278_abnormal_bone_marrow | 2.02515944 |
26 | MP0000716_abnormal_immune_system | 2.01291632 |
27 | MP0003866_abnormal_defecation | 1.99205573 |
28 | MP0002723_abnormal_immune_serum | 1.97819692 |
29 | MP0000703_abnormal_thymus_morphology | 1.97162463 |
30 | MP0005025_abnormal_response_to | 1.95073218 |
31 | MP0002429_abnormal_blood_cell | 1.93338363 |
32 | MP0005000_abnormal_immune_tolerance | 1.86868623 |
33 | MP0003077_abnormal_cell_cycle | 1.83536640 |
34 | MP0001873_stomach_inflammation | 1.80388039 |
35 | MP0002877_abnormal_melanocyte_morpholog | 1.80043085 |
36 | MP0010155_abnormal_intestine_physiology | 1.79676759 |
37 | MP0008007_abnormal_cellular_replicative | 1.72719593 |
38 | MP0005387_immune_system_phenotype | 1.71736442 |
39 | MP0001790_abnormal_immune_system | 1.71736442 |
40 | MP0003436_decreased_susceptibility_to | 1.71350046 |
41 | MP0001853_heart_inflammation | 1.71140328 |
42 | MP0005076_abnormal_cell_differentiation | 1.70449761 |
43 | MP0002405_respiratory_system_inflammati | 1.70123343 |
44 | MP0004233_abnormal_muscle_weight | 1.69836373 |
45 | MP0002166_altered_tumor_susceptibility | 1.69644444 |
46 | MP0005075_abnormal_melanosome_morpholog | 1.67315928 |
47 | MP0005464_abnormal_platelet_physiology | 1.66610224 |
48 | MP0010094_abnormal_chromosome_stability | 1.64271892 |
49 | MP0000747_muscle_weakness | 1.62136627 |
50 | MP0005666_abnormal_adipose_tissue | 1.61297375 |
51 | MP0003566_abnormal_cell_adhesion | 1.59571346 |
52 | MP0006054_spinal_hemorrhage | 1.59053335 |
53 | MP0003656_abnormal_erythrocyte_physiolo | 1.56801794 |
54 | MP0004957_abnormal_blastocyst_morpholog | 1.56520271 |
55 | MP0000759_abnormal_skeletal_muscle | 1.52478472 |
56 | MP0004858_abnormal_nervous_system | 1.48880388 |
57 | MP0002148_abnormal_hypersensitivity_rea | 1.47253294 |
58 | MP0005083_abnormal_biliary_tract | 1.41097458 |
59 | MP0004087_abnormal_muscle_fiber | 1.38507205 |
60 | MP0005174_abnormal_tail_pigmentation | 1.37496463 |
61 | MP0002019_abnormal_tumor_incidence | 1.37479229 |
62 | MP0003111_abnormal_nucleus_morphology | 1.36679728 |
63 | MP0003453_abnormal_keratinocyte_physiol | 1.34425471 |
64 | MP0002419_abnormal_innate_immunity | 1.33160795 |
65 | MP0005375_adipose_tissue_phenotype | 1.33050944 |
66 | MP0001849_ear_inflammation | 1.28884167 |
67 | MP0003724_increased_susceptibility_to | 1.28351576 |
68 | MP0002132_abnormal_respiratory_system | 1.28333835 |
69 | MP0003567_abnormal_fetal_cardiomyocyte | 1.28123191 |
70 | MP0002332_abnormal_exercise_endurance | 1.27743911 |
71 | MP0000313_abnormal_cell_death | 1.25827399 |
72 | MP0001845_abnormal_inflammatory_respons | 1.24831854 |
73 | MP0006036_abnormal_mitochondrial_physio | 1.20892526 |
74 | MP0005501_abnormal_skin_physiology | 1.20181453 |
75 | MP0003075_altered_response_to | 1.15310461 |
76 | MP0004147_increased_porphyrin_level | 1.15029040 |
77 | MP0003806_abnormal_nucleotide_metabolis | 1.15007638 |
78 | MP0008058_abnormal_DNA_repair | 1.13627924 |
79 | MP0005670_abnormal_white_adipose | 1.12593742 |
80 | MP0002796_impaired_skin_barrier | 1.11862749 |
81 | MP0002269_muscular_atrophy | 1.07605064 |
82 | MP0003329_amyloid_beta_deposits | 1.06070498 |
83 | MP0000003_abnormal_adipose_tissue | 1.05955003 |
84 | MP0005058_abnormal_lysosome_morphology | 1.05834236 |
85 | MP0003300_gastrointestinal_ulcer | 1.05155448 |
86 | MP0003943_abnormal_hepatobiliary_system | 1.04946519 |
87 | MP0003221_abnormal_cardiomyocyte_apopto | 1.04073017 |
88 | MP0004947_skin_inflammation | 1.03706041 |
89 | MP0000858_altered_metastatic_potential | 1.02258986 |
90 | MP0004036_abnormal_muscle_relaxation | 1.01562376 |
91 | MP0003828_pulmonary_edema | 1.01363215 |
92 | MP0000733_abnormal_muscle_development | 1.01072173 |
93 | MP0000358_abnormal_cell_content/ | 0.96800576 |
94 | MP0002998_abnormal_bone_remodeling | 0.95857374 |
95 | MP0002933_joint_inflammation | 0.95790969 |
96 | MP0008438_abnormal_cutaneous_collagen | 0.95732345 |
97 | MP0000477_abnormal_intestine_morphology | 0.95305969 |
98 | MP0002006_tumorigenesis | 0.93902034 |
99 | MP0001730_embryonic_growth_arrest | 0.93335048 |
100 | MP0003183_abnormal_peptide_metabolism | 0.93285348 |
101 | MP0002095_abnormal_skin_pigmentation | 0.92808876 |
102 | MP0005165_increased_susceptibility_to | 0.92480964 |
103 | MP0009840_abnormal_foam_cell | 0.92039955 |
104 | MP0003091_abnormal_cell_migration | 0.90102331 |
105 | MP0000350_abnormal_cell_proliferation | 0.89166328 |
106 | MP0001851_eye_inflammation | 0.87095281 |
107 | MP0006082_CNS_inflammation | 0.86375682 |
108 | MP0003646_muscle_fatigue | 0.85284053 |
109 | MP0008469_abnormal_protein_level | 0.85252135 |
110 | MP0005621_abnormal_cell_physiology | 0.84046188 |
111 | MP0001879_abnormal_lymphatic_vessel | 0.83455602 |
112 | MP0004084_abnormal_cardiac_muscle | 0.83452583 |
113 | MP0009931_abnormal_skin_appearance | 0.82867334 |
114 | MP0002080_prenatal_lethality | 0.82613893 |
115 | MP0003191_abnormal_cellular_cholesterol | 0.82443494 |
116 | MP0003279_aneurysm | 0.81203333 |
117 | MP0002106_abnormal_muscle_physiology | 0.80650050 |
118 | MP0000749_muscle_degeneration | 0.80635859 |
119 | MP0000678_abnormal_parathyroid_gland | 0.80574896 |
120 | MP0004145_abnormal_muscle_electrophysio | 0.78432216 |
121 | MP0000751_myopathy | 0.78356958 |
122 | MP0010630_abnormal_cardiac_muscle | 0.77910725 |
123 | MP0004510_myositis | 0.77724955 |
124 | MP0003303_peritoneal_inflammation | 0.75216722 |
125 | MP0001697_abnormal_embryo_size | 0.75058451 |
126 | MP0002653_abnormal_ependyma_morphology | 0.74685035 |
127 | MP0001663_abnormal_digestive_system | 0.72443691 |
128 | MP0000750_abnormal_muscle_regeneration | 0.71082682 |
129 | MP0002089_abnormal_postnatal_growth/wei | 0.70448348 |
130 | MP0000343_altered_response_to | 0.69676191 |
131 | MP0000371_diluted_coat_color | 0.68863847 |
132 | MP0004130_abnormal_muscle_cell | 0.68181107 |
133 | MP0008961_abnormal_basal_metabolism | 0.67776538 |
134 | MP0005330_cardiomyopathy | 0.66644192 |
135 | MP0010368_abnormal_lymphatic_system | 0.65340819 |
136 | MP0010352_gastrointestinal_tract_polyps | 0.64335138 |
137 | MP0003172_abnormal_lysosome_physiology | 0.62809438 |
138 | MP0001533_abnormal_skeleton_physiology | 0.62493969 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.81614318 |
2 | Chronic otitis media (HP:0000389) | 4.48604376 |
3 | IgM deficiency (HP:0002850) | 4.45137397 |
4 | Reticulocytopenia (HP:0001896) | 4.20392748 |
5 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.12265173 |
6 | Abnormal number of erythroid precursors (HP:0012131) | 3.97772609 |
7 | Thrombocytosis (HP:0001894) | 3.90167137 |
8 | Distal lower limb muscle weakness (HP:0009053) | 3.77960188 |
9 | Abnormality of the nasal mucosa (HP:0000433) | 3.74460591 |
10 | Increased connective tissue (HP:0009025) | 3.59412910 |
11 | Recurrent bronchitis (HP:0002837) | 3.56514220 |
12 | Nemaline bodies (HP:0003798) | 3.50422853 |
13 | Muscle fiber inclusion bodies (HP:0100299) | 3.46634533 |
14 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.42129017 |
15 | Aplastic anemia (HP:0001915) | 3.37566190 |
16 | Distal lower limb amyotrophy (HP:0008944) | 3.31082764 |
17 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.29694555 |
18 | Panhypogammaglobulinemia (HP:0003139) | 3.25897533 |
19 | Vertebral compression fractures (HP:0002953) | 3.19623198 |
20 | Nasal polyposis (HP:0100582) | 3.14225678 |
21 | Type 1 muscle fiber predominance (HP:0003803) | 3.06467563 |
22 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.05831455 |
23 | Large eyes (HP:0001090) | 3.04532089 |
24 | Ragged-red muscle fibers (HP:0003200) | 3.00952951 |
25 | Petechiae (HP:0000967) | 2.96703090 |
26 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.92803358 |
27 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.92803358 |
28 | Fatigue (HP:0012378) | 2.83279710 |
29 | Achilles tendon contracture (HP:0001771) | 2.82797881 |
30 | Pallor (HP:0000980) | 2.80637169 |
31 | Poikiloderma (HP:0001029) | 2.76830897 |
32 | Increased variability in muscle fiber diameter (HP:0003557) | 2.74929803 |
33 | Gastrointestinal inflammation (HP:0004386) | 2.72423077 |
34 | Gastrointestinal stroma tumor (HP:0100723) | 2.71656391 |
35 | Agammaglobulinemia (HP:0004432) | 2.71517900 |
36 | Cellulitis (HP:0100658) | 2.70880334 |
37 | Recurrent viral infections (HP:0004429) | 2.65678183 |
38 | Abnormality of T cell physiology (HP:0011840) | 2.65021688 |
39 | Hepatocellular necrosis (HP:0001404) | 2.65008414 |
40 | Abnormality of T cells (HP:0002843) | 2.63324691 |
41 | Reticulocytosis (HP:0001923) | 2.62322775 |
42 | Eczematoid dermatitis (HP:0000976) | 2.57794913 |
43 | Difficulty climbing stairs (HP:0003551) | 2.51794461 |
44 | Abnormality of the Achilles tendon (HP:0005109) | 2.50721595 |
45 | Asymmetric septal hypertrophy (HP:0001670) | 2.48738897 |
46 | Inflammation of the large intestine (HP:0002037) | 2.46497031 |
47 | Myositis (HP:0100614) | 2.45285462 |
48 | Abnormal gallbladder physiology (HP:0012438) | 2.45280061 |
49 | Cholecystitis (HP:0001082) | 2.45280061 |
50 | Neck muscle weakness (HP:0000467) | 2.44400262 |
51 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.43793629 |
52 | Increased serum ferritin (HP:0003281) | 2.42269606 |
53 | Colitis (HP:0002583) | 2.42022453 |
54 | Hepatic necrosis (HP:0002605) | 2.39226943 |
55 | Microretrognathia (HP:0000308) | 2.38316181 |
56 | Abnormality of B cell number (HP:0010975) | 2.38101104 |
57 | B lymphocytopenia (HP:0010976) | 2.38101104 |
58 | Polycythemia (HP:0001901) | 2.36428308 |
59 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.36052556 |
60 | EMG: myopathic abnormalities (HP:0003458) | 2.36024164 |
61 | Bulbar palsy (HP:0001283) | 2.35159649 |
62 | Lymphopenia (HP:0001888) | 2.34835947 |
63 | Chronic sinusitis (HP:0011109) | 2.32734169 |
64 | Prolonged bleeding time (HP:0003010) | 2.32269720 |
65 | Muscle fiber atrophy (HP:0100295) | 2.28445071 |
66 | Interstitial pulmonary disease (HP:0006530) | 2.28179786 |
67 | Recurrent fungal infections (HP:0002841) | 2.27746003 |
68 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.26081913 |
69 | Spontaneous hematomas (HP:0007420) | 2.26058004 |
70 | Macrocytic anemia (HP:0001972) | 2.25773266 |
71 | Muscle stiffness (HP:0003552) | 2.23450378 |
72 | IgG deficiency (HP:0004315) | 2.23365872 |
73 | Muscle fiber splitting (HP:0003555) | 2.22878387 |
74 | Increased muscle lipid content (HP:0009058) | 2.22197576 |
75 | Bronchitis (HP:0012387) | 2.20808012 |
76 | Albinism (HP:0001022) | 2.19802017 |
77 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.17854900 |
78 | Lymphoma (HP:0002665) | 2.16104667 |
79 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.15909359 |
80 | Cholelithiasis (HP:0001081) | 2.13965916 |
81 | Increased intramyocellular lipid droplets (HP:0012240) | 2.13677521 |
82 | Recurrent abscess formation (HP:0002722) | 2.13628711 |
83 | Hyporeflexia of lower limbs (HP:0002600) | 2.12860999 |
84 | Type I transferrin isoform profile (HP:0003642) | 2.12093019 |
85 | Hyperacusis (HP:0010780) | 2.10909649 |
86 | Dysostosis multiplex (HP:0000943) | 2.09921775 |
87 | Meningitis (HP:0001287) | 2.09233303 |
88 | Hypertensive crisis (HP:0100735) | 2.08656297 |
89 | Microcytic anemia (HP:0001935) | 2.08364928 |
90 | Abnormality of glycolipid metabolism (HP:0010969) | 2.08072927 |
91 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.08072927 |
92 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.08072927 |
93 | Hypertriglyceridemia (HP:0002155) | 2.05941703 |
94 | Verrucae (HP:0200043) | 2.05704388 |
95 | Papilloma (HP:0012740) | 2.05704388 |
96 | Round ear (HP:0100830) | 2.05511608 |
97 | Type 2 muscle fiber atrophy (HP:0003554) | 2.04797087 |
98 | Protrusio acetabuli (HP:0003179) | 2.04744497 |
99 | T lymphocytopenia (HP:0005403) | 2.02035817 |
100 | Emphysema (HP:0002097) | 2.01935729 |
101 | Pustule (HP:0200039) | 2.01442816 |
102 | Abnormal protein glycosylation (HP:0012346) | 2.01331211 |
103 | Abnormal glycosylation (HP:0012345) | 2.01331211 |
104 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.01331211 |
105 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.01331211 |
106 | Hepatosplenomegaly (HP:0001433) | 2.00799159 |
107 | Spinal rigidity (HP:0003306) | 1.99946761 |
108 | Obstructive lung disease (HP:0006536) | 1.99769270 |
109 | Chronic obstructive pulmonary disease (HP:0006510) | 1.99769270 |
110 | Easy fatigability (HP:0003388) | 1.98247767 |
111 | Lower limb amyotrophy (HP:0007210) | 1.96958635 |
112 | Impaired platelet aggregation (HP:0003540) | 1.96848716 |
113 | Abnormal platelet function (HP:0011869) | 1.96848716 |
114 | Annular pancreas (HP:0001734) | 1.95792639 |
115 | Ulnar deviation of the wrist (HP:0003049) | 1.95605156 |
116 | Basal cell carcinoma (HP:0002671) | 1.94911023 |
117 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.93718676 |
118 | Purpura (HP:0000979) | 1.93345800 |
119 | Generalized amyotrophy (HP:0003700) | 1.93318664 |
120 | Myopathic facies (HP:0002058) | 1.89183234 |
121 | Growth hormone excess (HP:0000845) | 1.88743673 |
122 | Increased cerebral lipofuscin (HP:0011813) | 1.87479031 |
123 | Abnormality of iron homeostasis (HP:0011031) | 1.86789532 |
124 | J-shaped sella turcica (HP:0002680) | 1.85579644 |
125 | Abnormality of macrophages (HP:0004311) | 1.84759154 |
126 | Abnormality of the thoracic spine (HP:0100711) | 1.83010077 |
127 | Abnormality of T cell number (HP:0011839) | 1.82833127 |
128 | Recurrent bacterial skin infections (HP:0005406) | 1.82619845 |
129 | Ventricular tachycardia (HP:0004756) | 1.82123553 |
130 | Pancytopenia (HP:0001876) | 1.81198421 |
131 | Broad face (HP:0000283) | 1.80425737 |
132 | Distal upper limb amyotrophy (HP:0007149) | 1.80292971 |
133 | Upper limb amyotrophy (HP:0009129) | 1.80292971 |
134 | Hypergammaglobulinemia (HP:0010702) | 1.80142752 |
135 | Difficulty running (HP:0009046) | 1.80127262 |
136 | Asplenia (HP:0001746) | 1.79828886 |
137 | Thoracic kyphosis (HP:0002942) | 1.77857678 |
138 | Rhabdomyolysis (HP:0003201) | 1.77824651 |
139 | Epistaxis (HP:0000421) | 1.77746065 |
140 | Amyloidosis (HP:0011034) | 1.77464581 |
141 | Calcaneovalgus deformity (HP:0001848) | 1.77088534 |
142 | Colon cancer (HP:0003003) | 1.75967624 |
143 | Back pain (HP:0003418) | 1.75418023 |
144 | Exertional dyspnea (HP:0002875) | 1.74960084 |
145 | Foot dorsiflexor weakness (HP:0009027) | 1.74731406 |
146 | Exercise-induced muscle cramps (HP:0003710) | 1.74694563 |
147 | Mediastinal lymphadenopathy (HP:0100721) | 1.74562945 |
148 | Limb-girdle muscle atrophy (HP:0003797) | 1.72813243 |
149 | Neutropenia (HP:0001875) | 1.72120048 |
150 | Granulocytopenia (HP:0001913) | 1.71919875 |
151 | Posterior subcapsular cataract (HP:0007787) | 1.71562775 |
152 | Axonal loss (HP:0003447) | 1.71158780 |
153 | Abnormal gallbladder morphology (HP:0012437) | 1.70386372 |
154 | Premature rupture of membranes (HP:0001788) | 1.70268787 |
155 | Myoglobinuria (HP:0002913) | 1.69189525 |
156 | Loss of speech (HP:0002371) | 1.69084410 |
157 | Leukocytosis (HP:0001974) | 1.68456729 |
158 | Amaurosis fugax (HP:0100576) | 1.68400154 |
159 | Scapular winging (HP:0003691) | 1.68378795 |
160 | Central scotoma (HP:0000603) | 1.67943028 |
161 | Poor head control (HP:0002421) | 1.67706214 |
162 | Progressive muscle weakness (HP:0003323) | 1.67555133 |
163 | Abnormality of the anterior horn cell (HP:0006802) | 1.66643549 |
164 | Degeneration of anterior horn cells (HP:0002398) | 1.66643549 |
165 | Stridor (HP:0010307) | 1.65983501 |
166 | Trismus (HP:0000211) | 1.65524462 |
167 | Exercise-induced myalgia (HP:0003738) | 1.65195993 |
168 | Vacuolated lymphocytes (HP:0001922) | 1.64741673 |
169 | Increased serum lactate (HP:0002151) | 1.64725560 |
170 | Hemorrhage of the eye (HP:0011885) | 1.64224590 |
171 | Increased IgE level (HP:0003212) | 1.62845391 |
172 | Gastrointestinal dysmotility (HP:0002579) | 1.62439147 |
173 | Polygenic inheritance (HP:0010982) | 1.62192489 |
174 | Abnormality of reticulocytes (HP:0004312) | 1.61763757 |
175 | Hypercortisolism (HP:0001578) | 1.61057518 |
176 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.60547841 |
177 | Upper motor neuron abnormality (HP:0002127) | 1.58895986 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 3.54813905 |
2 | EEF2K | 3.15320361 |
3 | PRPF4B | 3.01540872 |
4 | NME2 | 2.94767525 |
5 | MAP3K10 | 2.90845957 |
6 | SMG1 | 2.64586504 |
7 | IRAK3 | 2.56236721 |
8 | DYRK3 | 2.45951560 |
9 | FLT3 | 2.14667785 |
10 | TGFBR1 | 2.11704654 |
11 | MAP3K11 | 2.10886868 |
12 | SIK1 | 2.08328955 |
13 | PKN2 | 2.07809347 |
14 | BCKDK | 2.07593386 |
15 | TGFBR2 | 2.01009296 |
16 | KDR | 1.90995803 |
17 | BUB1 | 1.88269841 |
18 | BTK | 1.87607765 |
19 | RPS6KA4 | 1.86250957 |
20 | TRIB3 | 1.85078159 |
21 | ICK | 1.84067451 |
22 | KIT | 1.82472730 |
23 | ZAP70 | 1.73935707 |
24 | LRRK2 | 1.66890786 |
25 | EPHA2 | 1.65391814 |
26 | TESK2 | 1.64011210 |
27 | STK16 | 1.62842176 |
28 | TIE1 | 1.61745692 |
29 | ERN1 | 1.58738989 |
30 | ARAF | 1.54589061 |
31 | TBK1 | 1.51016664 |
32 | JAK3 | 1.46201676 |
33 | SCYL2 | 1.46108415 |
34 | MAPKAPK3 | 1.44772592 |
35 | MAP2K3 | 1.41992253 |
36 | RPS6KB2 | 1.40870190 |
37 | TLK1 | 1.38240095 |
38 | NEK2 | 1.37884290 |
39 | TXK | 1.37340718 |
40 | WEE1 | 1.36009227 |
41 | GRK6 | 1.35634260 |
42 | BLK | 1.32835078 |
43 | RIPK1 | 1.28989996 |
44 | FGFR4 | 1.28634943 |
45 | VRK2 | 1.28497562 |
46 | ACVR1B | 1.27702572 |
47 | SYK | 1.25328363 |
48 | CDK19 | 1.24222105 |
49 | STK10 | 1.19955255 |
50 | TEC | 1.17161482 |
51 | EPHB1 | 1.14886343 |
52 | ITK | 1.11882610 |
53 | PIM2 | 1.11313653 |
54 | MAP3K1 | 1.10353994 |
55 | CSF1R | 1.09859463 |
56 | EIF2AK1 | 1.04529162 |
57 | TYK2 | 0.97318619 |
58 | TAOK3 | 0.96928534 |
59 | OBSCN | 0.96799199 |
60 | BMX | 0.95358154 |
61 | PAK4 | 0.94768662 |
62 | DYRK1B | 0.92622841 |
63 | RIPK4 | 0.88868298 |
64 | ILK | 0.88212926 |
65 | IKBKE | 0.87258197 |
66 | MAPK11 | 0.85080709 |
67 | CCNB1 | 0.85050054 |
68 | TTN | 0.82916291 |
69 | MATK | 0.81037228 |
70 | PASK | 0.80660408 |
71 | LIMK1 | 0.78338380 |
72 | IRAK2 | 0.77710747 |
73 | CDK4 | 0.74498525 |
74 | PIM1 | 0.74183778 |
75 | ABL2 | 0.73982682 |
76 | MAP3K6 | 0.73603816 |
77 | MARK2 | 0.73446112 |
78 | BRAF | 0.71081882 |
79 | PRKD2 | 0.70028959 |
80 | LCK | 0.69569966 |
81 | MAP3K8 | 0.69297077 |
82 | LYN | 0.69171790 |
83 | RAF1 | 0.67148334 |
84 | NLK | 0.66850880 |
85 | CDK12 | 0.66737210 |
86 | PDPK1 | 0.66647544 |
87 | MAPK12 | 0.62704874 |
88 | TAOK2 | 0.62641560 |
89 | KSR2 | 0.61272537 |
90 | MST1R | 0.60198117 |
91 | HIPK2 | 0.60048389 |
92 | IRAK4 | 0.59967866 |
93 | MAP3K7 | 0.59663835 |
94 | TNK2 | 0.59451985 |
95 | FES | 0.58778640 |
96 | IKBKB | 0.58012779 |
97 | MOS | 0.55746817 |
98 | TAOK1 | 0.54197991 |
99 | MAP3K13 | 0.53983522 |
100 | CSK | 0.53960090 |
101 | RPS6KA2 | 0.53703488 |
102 | DAPK1 | 0.53447814 |
103 | CDK7 | 0.53313748 |
104 | MAP3K14 | 0.52897695 |
105 | CLK1 | 0.52684445 |
106 | HCK | 0.51792659 |
107 | AURKB | 0.50107810 |
108 | PHKG1 | 0.49874424 |
109 | PHKG2 | 0.49874424 |
110 | * MTOR | 0.49570104 |
111 | CAMKK2 | 0.49119507 |
112 | MYLK | 0.48500725 |
113 | MAPK15 | 0.48500695 |
114 | LMTK2 | 0.47794165 |
115 | VRK1 | 0.47592957 |
116 | MAP2K2 | 0.47052385 |
117 | RPS6KA6 | 0.46543163 |
118 | PRKG2 | 0.45277316 |
119 | CDC42BPA | 0.45037354 |
120 | RPS6KA5 | 0.44280160 |
121 | STK4 | 0.43910827 |
122 | TESK1 | 0.43353928 |
123 | MAP3K3 | 0.42886492 |
124 | ATR | 0.42802074 |
125 | MUSK | 0.42552375 |
126 | AURKA | 0.41058766 |
127 | PTK6 | 0.40854958 |
128 | MAPK4 | 0.39815442 |
129 | BRSK1 | 0.39769125 |
130 | MAP2K6 | 0.38760886 |
131 | PDK1 | 0.38436295 |
132 | PTK2 | 0.38214911 |
133 | MAPKAPK2 | 0.37593750 |
134 | SIK3 | 0.35845058 |
135 | RPS6KL1 | 0.34523618 |
136 | RPS6KC1 | 0.34523618 |
137 | NEK1 | 0.33248568 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ribosome_Homo sapiens_hsa03010 | 4.45010413 |
2 | DNA replication_Homo sapiens_hsa03030 | 3.54000944 |
3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.04148884 |
4 | Mismatch repair_Homo sapiens_hsa03430 | 2.74887464 |
5 | Base excision repair_Homo sapiens_hsa03410 | 2.70891520 |
6 | Spliceosome_Homo sapiens_hsa03040 | 2.62029763 |
7 | Proteasome_Homo sapiens_hsa03050 | 2.08398241 |
8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.05552801 |
9 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.01942298 |
10 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.81476229 |
11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.69046433 |
12 | Sulfur relay system_Homo sapiens_hsa04122 | 1.68860463 |
13 | Bladder cancer_Homo sapiens_hsa05219 | 1.65419261 |
14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.60438640 |
15 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.60389616 |
16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.53823737 |
17 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.53567915 |
18 | RNA polymerase_Homo sapiens_hsa03020 | 1.45043337 |
19 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.42876113 |
20 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.41077673 |
21 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.39476958 |
22 | Shigellosis_Homo sapiens_hsa05131 | 1.37869207 |
23 | RNA transport_Homo sapiens_hsa03013 | 1.36207314 |
24 | Cell cycle_Homo sapiens_hsa04110 | 1.34744366 |
25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.34225031 |
26 | Measles_Homo sapiens_hsa05162 | 1.31509988 |
27 | Leishmaniasis_Homo sapiens_hsa05140 | 1.31252283 |
28 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.29800108 |
29 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.29488710 |
30 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.27882453 |
31 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.26428747 |
32 | Homologous recombination_Homo sapiens_hsa03440 | 1.26338761 |
33 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.25607474 |
34 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.23570808 |
35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.23282082 |
36 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.21199032 |
37 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.18727596 |
38 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.17899864 |
39 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.17125560 |
40 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.15674695 |
41 | Apoptosis_Homo sapiens_hsa04210 | 1.15214515 |
42 | Lysosome_Homo sapiens_hsa04142 | 1.12758982 |
43 | Legionellosis_Homo sapiens_hsa05134 | 1.11468668 |
44 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.09404740 |
45 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.07596255 |
46 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.07229598 |
47 | Endometrial cancer_Homo sapiens_hsa05213 | 1.05888323 |
48 | RNA degradation_Homo sapiens_hsa03018 | 1.05216021 |
49 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.04571014 |
50 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.04290324 |
51 | Other glycan degradation_Homo sapiens_hsa00511 | 1.04260319 |
52 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.03977409 |
53 | Hepatitis C_Homo sapiens_hsa05160 | 1.01103712 |
54 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.99753457 |
55 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.97957165 |
56 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.97883446 |
57 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.97660743 |
58 | Endocytosis_Homo sapiens_hsa04144 | 0.97348162 |
59 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.96271908 |
60 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.96117869 |
61 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.94975101 |
62 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.94846285 |
63 | Viral myocarditis_Homo sapiens_hsa05416 | 0.92037261 |
64 | Colorectal cancer_Homo sapiens_hsa05210 | 0.91651264 |
65 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.89904728 |
66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.89113021 |
67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88567343 |
68 | Hepatitis B_Homo sapiens_hsa05161 | 0.87871628 |
69 | HTLV-I infection_Homo sapiens_hsa05166 | 0.87732257 |
70 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.87357974 |
71 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.87202615 |
72 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.85977705 |
73 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.85766423 |
74 | Malaria_Homo sapiens_hsa05144 | 0.84309812 |
75 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.83019792 |
76 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.80984954 |
77 | Thyroid cancer_Homo sapiens_hsa05216 | 0.79796777 |
78 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.79722022 |
79 | Insulin resistance_Homo sapiens_hsa04931 | 0.79624551 |
80 | Prion diseases_Homo sapiens_hsa05020 | 0.78341221 |
81 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.77735207 |
82 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.77442399 |
83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.77387338 |
84 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.76172023 |
85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.75956880 |
86 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.75679210 |
87 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.75555463 |
88 | Platelet activation_Homo sapiens_hsa04611 | 0.75262272 |
89 | Purine metabolism_Homo sapiens_hsa00230 | 0.75023092 |
90 | Parkinsons disease_Homo sapiens_hsa05012 | 0.72775698 |
91 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.72658789 |
92 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.70354971 |
93 | Galactose metabolism_Homo sapiens_hsa00052 | 0.69721236 |
94 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.69436476 |
95 | Influenza A_Homo sapiens_hsa05164 | 0.68323663 |
96 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.67724774 |
97 | Glioma_Homo sapiens_hsa05214 | 0.67121748 |
98 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.66720554 |
99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.65494323 |
100 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.63718727 |
101 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.62788748 |
102 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.62124192 |
103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61642115 |
104 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.60541267 |
105 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.59942990 |
106 | Alcoholism_Homo sapiens_hsa05034 | 0.59557078 |
107 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.59447551 |
108 | Focal adhesion_Homo sapiens_hsa04510 | 0.58995898 |
109 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.58937646 |
110 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58441184 |
111 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.57037071 |
112 | Basal transcription factors_Homo sapiens_hsa03022 | 0.56444528 |
113 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.55627078 |
114 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.55172121 |
115 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.54797726 |
116 | Carbon metabolism_Homo sapiens_hsa01200 | 0.54160901 |
117 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.54135634 |
118 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.53792659 |
119 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.53702911 |
120 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.53521850 |
121 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.52012201 |
122 | Amoebiasis_Homo sapiens_hsa05146 | 0.51818997 |
123 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49891401 |
124 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.49383116 |
125 | Salmonella infection_Homo sapiens_hsa05132 | 0.48136712 |
126 | Tuberculosis_Homo sapiens_hsa05152 | 0.47206565 |
127 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.46905582 |
128 | Protein export_Homo sapiens_hsa03060 | 0.46334018 |
129 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46029317 |
130 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.41419965 |
131 | Pertussis_Homo sapiens_hsa05133 | 0.41045391 |
132 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.40628665 |
133 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.40019199 |
134 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.39997100 |
135 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.39389741 |
136 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.38448166 |
137 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.38100155 |